Stock NEXUSSURGL NEXUS SURGICAL AND MEDICARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nexus Surgical and Medicare Limited

Equities

NEXUSSURGL

INE370Q01015

Medical Equipment, Supplies & Distribution

Market Closed - Bombay S.E.
Other stock markets
 06:01:01 2024-07-05 EDT 		5-day change 1st Jan Change
15.5 INR -1.34% Intraday chart for Nexus Surgical and Medicare Limited +8.85% +34.20%
05-30 Nexus Surgical and Medicare Limited Appoints Ashish Durgaprasad Mishra as Additional Director - Non- Executive Professional Director CI
05-30 Nexus Surgical and Medicare Limited Appoints Surya Kant Modi as Additional Director - Independent Non-Executive Director CI

Valuation

Fiscal Period: Maart 2018 2019 2020 2021 2022 2023
Capitalization 1 309.2 85.36 70.59 18.88 41.26 47.33
Enterprise Value (EV) 1 311.2 87.36 70.33 16.63 39.76 40.4
P/E ratio -94.2 x -76.6 x -1.33 x 12.3 x 14.2 x 27.9 x
Yield - - - - - -
Capitalization / Revenue 29.7 x 3.85 x 4.07 x 0.5 x 1.72 x 3.05 x
EV / Revenue 29.9 x 3.94 x 4.06 x 0.44 x 1.66 x 2.6 x
EV / EBITDA -97.9 x -83.4 x 95.6 x 9.61 x 10.8 x 18.7 x
EV / FCF 1,152 x 202 x 27 x 8.16 x -81.6 x 12.4 x
FCF Yield 0.09% 0.5% 3.7% 12.3% -1.23% 8.08%
Price to Book 6.01 x 1.7 x -26.9 x -17.5 x 22.6 x 13.4 x
Nbr of stocks (in thousands) 5,472 5,472 5,472 5,472 5,472 5,472
Reference price 2 56.50 15.60 12.90 3.450 7.540 8.650
Announcement Date 10/22/18 9/6/19 9/3/20 9/4/21 9/7/22 8/22/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Maart 2018 2019 2020 2021 2022 2023
Net sales 1 10.42 22.15 17.32 37.53 23.95 15.53
EBITDA 1 -3.18 -1.048 0.7355 1.73 3.681 2.165
EBIT 1 -3.206 -1.074 0.7092 1.704 3.653 2.151
Operating Margin -30.78% -4.85% 4.09% 4.54% 15.25% 13.85%
Earnings before Tax (EBT) 1 -3.208 -1.075 -52.8 1.704 3.881 2.288
Net income 1 -3.261 -1.114 -52.96 1.54 2.902 1.707
Net margin -31.3% -5.03% -305.71% 4.1% 12.12% 10.99%
EPS 2 -0.6000 -0.2037 -9.680 0.2800 0.5300 0.3100
Free Cash Flow 1 0.2702 0.4325 2.606 2.039 -0.4874 3.262
FCF margin 2.59% 1.95% 15.04% 5.43% -2.03% 21%
FCF Conversion (EBITDA) - - 354.26% 117.86% - 150.68%
FCF Conversion (Net income) - - - 132.42% - 191.1%
Dividend per Share - - - - - -
Announcement Date 10/22/18 9/6/19 9/3/20 9/4/21 9/7/22 8/22/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Maart 2018 2019 2020 2021 2022 2023
Net Debt 1 2.08 2 - - - -
Net Cash position 1 - - 0.26 2.25 1.5 6.94
Leverage (Debt/EBITDA) -0.653 x -1.906 x - - - -
Free Cash Flow 1 0.27 0.43 2.61 2.04 -0.49 3.26
ROE (net income / shareholders' equity) -6.14% -2.19% -222% -83.3% 781% 63.8%
ROA (Net income/ Total Assets) -3.48% -1.21% 1.55% 18.6% 15.5% 9.21%
Assets 1 93.79 92.04 -3,412 8.296 18.68 18.53
Book Value Per Share 2 9.400 9.200 -0.4800 -0.2000 0.3300 0.6500
Cash Flow per Share 2 0.0200 0.0800 0.0400 0.4000 0.2000 1.190
Capex - - - - 0.01 0.06
Capex / Sales - - - - 0.05% 0.41%
Announcement Date 10/22/18 9/6/19 9/3/20 9/4/21 9/7/22 8/22/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
NEXUS SURGICAL AND MEDICARE LIMITED Stock Nexus Surgical and Medicare Limited
+34.20% 1.02M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.50% 181B
MEDTRONIC PLC Stock Medtronic plc
-5.79% 99.52B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.59% 65.82B
DEXCOM, INC. Stock DexCom, Inc.
-8.38% 45.21B
CENCORA, INC. Stock Cencora, Inc.
+8.42% 43.85B
HOYA CORPORATION Stock Hoya Corporation
+10.10% 42.17B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+10.97% 28.75B
TERUMO CORPORATION Stock Terumo Corporation
+18.89% 25.39B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.39% 23.5B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. NEXUSSURGL Stock
  4. Financials Nexus Surgical and Medicare Limited